Cargando…

Atovaquone exerts its anticancer effect by inhibiting Na(+)/K(+)-ATPase ion transport in canine cancer cells

BACKGROUND AND AIM: New anticancer drugs are being developed to avoid the toxicity and chemoresistance of the currently available drugs. The Food and Drug Administration-approved anti-malarial drug atovaquone is known to act as a selective oxidative phosphorylation inhibitor in the mitochondria by c...

Descripción completa

Detalles Bibliográficos
Autor principal: Alharbi, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421541/
https://www.ncbi.nlm.nih.gov/pubmed/37577204
http://dx.doi.org/10.14202/vetworld.2023.1185-1192

Ejemplares similares